1-800-729-1232

NDMA

First Valsartan NDMA Cancer Lawsuit Cleared to Proceed to Trial

Product Liability / April 12, 2024 / 4 minutes of reading / By / , , , , , , , , , , , , , , ,

More than five years after the initial valsartan recalls, the U.S. District Judge overseeing the valsartan litigation has greenlit the first trial against manufacturers and distributors of the tainted generic blood pressure drug. Over 1,200 valsartan lawsuits have been filed, with individuals alleging that changes to the manufacturing process resulted in the distribution of valsartan …

First Valsartan NDMA Cancer Lawsuit Cleared to Proceed to Trial Read More »

FDA Calls for Immediate Removal of All Zantac, Ranitidine Products from the Market

Personal Injury / September 19, 2023 / 4 minutes of reading / By / , , , , , , ,

The U.S. Food and Drug Administration (FDA) announced this week that it is asking manufacturers of Zantac and generic ranitidine products to withdraw all prescription and over-the-counter (OTC) versions of the drug from the market immediately. The FDA’s decision is the latest step in an ongoing investigation into the presence of a carcinogenic chemical called …

FDA Calls for Immediate Removal of All Zantac, Ranitidine Products from the Market Read More »

Lawsuit Alleges Side Effects of Zantac Caused Prostate Cancer Diagnosis

Personal Injury / November 6, 2023 / 4 minutes of reading / By / , , , , , ,

A new product liability lawsuit filed in federal court in Alabama alleges that side effects of the popular heartburn drug Zantac exposed an Alabama man to carcinogenic chemicals for years, ultimately leading to his prostate cancer diagnosis. Based on recent testing by an independent laboratory and widespread drug recalls affecting nearly every version of Zantac …

Lawsuit Alleges Side Effects of Zantac Caused Prostate Cancer Diagnosis Read More »

Scroll to Top